Home
Search

Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
BIO Launches “The Fight of Our Lives,” a National…
WASHINGTON, DC – Today, the Biotechnology Innovation Organization (BIO) announced the launch of ​​The Fight of Our Lives, a new national campaign focused on the stories behind biotechnology breakthroughs, the patients whose lives depend on them…
Learn more
BIO Statement on the Section 232 Pharmaceutical…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on Section 232 Pharmaceutical Proclamation.“A thriving American biotechnology ecosystem is essential to…
Learn more
BIO Statement on Passage of Legislation…
WASHINGTON, D.C. - Brad Zakes, senior vice president for emerging companies and economic affairs at the Biotechnology Innovation Organization (BIO), released the following statement on passage of legislation reauthorizing the SBIR/STTR program:"The…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
New Strategic Vision for Biotechnology Innovation Organization
October 27, 2020
The Biotechnology Innovation Organization (BIO) today announced a new, strategic direction that will help guide it to achieving long-term goals while maintaining responsiveness to changing political headwinds. Announcing the new vision, mission and…
BIO’s Dr. McMurry-Heath Applauds FDA Release of Guidance for Covid-19 Vaccines
October 6, 2020
Dr. Michelle McMurry-Heath, the president and CEO of the Biotechnology Innovation Organization (BIO), today applauded the Food and Drug Administration (FDA) for publicly releasing new guidance related to the emergency use authorization of future…
BIO Appoints New CFO
October 6, 2020
The Biotechnology Innovation Organization (BIO) announced today the retirement of Senior Vice President and Chief Financial Officer (CFO), Yvette White-Wiggins, after a distinguished 18-year career with the organization. White-Wiggins rose through…
BIO’s Dr. McMurry-Heath Calls on HHS Sec. Azar to Publicly Release FDA Guidance on Emergency Use Authorization for Covid-19 Vaccines
October 2, 2020
Dr. Michelle McMurry-Heath, the president and CEO of the Biotechnology Innovation Organization (BIO), released a letter today urging Health and Human Services (HHS) Secretary Alex Azar to “publicly release all new guidance developed by the Food and…
North Carolina Governor Roy Cooper Named BIO’s Governor of the Year
October 2, 2020
BIO recognizes Governor Cooper’s leadership in biotechnology & innovation Today, the Biotechnology Innovation Organization awarded Roy Cooper, Governor of North Carolina, with its 2020 Governor of the Year Award. Governor Cooper was presented…
Gov. Hogan, Novavax’ Erck, & BIO’s Dr. McMurry-Heath Toured Novavax Labs and Discussed Progress on COVID-19 Vaccine
September 24, 2020
Event Highlighted Leadership in Vaccine Development and Regional Growth in Biotechnology Innovation Gaithersburg, MD (September 24, 2020) – Today, Maryland Governor Larry Hogan and Dr. Michelle McMurry-Heath, President & CEO of Biotechnology…
BIO Presents Leadership and Legacy Award to Sharon Bomer Lauritsen
September 22, 2020
Washington, D.C. (September 22, 2020) –The Biotechnology Innovation Organization (BIO) today presented Sharon Bomer Lauritsen, founder of AgTrade Strategies LLC, former Assistant United States Trade Representative for Agricultural Affairs and…
BIO Announces 2020 BIO IMPACT Award Winners
September 18, 2020
Washington, D.C. (September 17, 2020) – The Biotechnology Innovation Organization (BIO) announced Dr. Pramod Chaudhari, Executive Chairman of Praj Industries Limited, as the winner of the 2020 George Washington Carver Award for Innovation in…
Senator Stabenow, BIO CEO, and Industry Leaders to Convene BIO IMPACT “Justice Through Science” Plenary
September 15, 2020
Washington, D.C. (September 15, 2020) – Next week at BIO IMPACT Digital (Sept. 21-22), Sen. Debbie Stabenow (D-MI) will join a panel of women leaders in the bioeconomy for a timely discussion about how smart policy can drive scientific …
BIO’s Dr. McMurry-Heath Says Adopting Foreign Price Controls a “Reckless Scheme” that will “Eliminate Hope for Vulnerable Seniors”
September 13, 2020
Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), issued the following statement after the Trump administration moved forward with its threat to impose foreign price controls on medicines covered under…